On Wednesday, the U.S. Supreme Court ruled it will hear a case regarding how patients can access a common abortion drug.
The FDA first approved Mifepristone in 2000, with patients being prescribed the pill following three doctor visits. NPR reported that the FDA relaxed those rules in recent years, allowing patients to get the prescription through telemedicine appointments, and receive the pills in the mail.
In April, Texas U.S. District Judge Matthew Kacsmaryk issued a nationwide ban on Mifepristone — finding the FDA improperly approved the drug. The pill, which is the most common form of abortion, terminates pregnancies up to 10 weeks gestation.
The Alliance for Hippocratic Medicine, a group of anti-abortion doctors, introduced the case, claiming the FDA overlooked the drug’s dangers and continued to do so while expanding its access. However, the FDA has argued that the drug has a lower rate of complications than Tylenol or Viagra.
Politico reported that the Supreme Court will hear the case in the spring — nearly two years after it overturned Roe v. Wade. Mifepristone will remain available in the meantime.
For the latest true crime and justice news, subscribe to the ‘Crime Stories with Nancy Grace’ podcast. Listen to the latest episode:
[Featured image: Pixabay]
